L
LequteMan
Guest
GSK Nigeria this week reports that its profits from January to September of this year dropped 23% compared to the same time period last year, a bad news for investors. The stock has fallen nearly 16% over the past thirty days and now trades at its lowest price in 16 months.
However, an investment analyst- Ryan Hoover of InvestinginAfrica, believes this is an opportunity to make some cash from the situation. Citing some conditions, facts and assumptions, he believes the company's stock is about to rise tremendously- if the situation persists for a short while.
"Under these assumptions, the company’s share price five years from now would rise to NGN83.85 from its current level of NGN54.00. If we add five years of dividends to that price, investors would reap an annualized return of 11.4%."
"As for me, I’m staying on the sidelines for the time being, but if the stock’s price drops further on no substantive news, I may be enticed to pick up a few shares," he wrote.
click here to read his article
#RyanHoover #Nigeria #GSK
However, an investment analyst- Ryan Hoover of InvestinginAfrica, believes this is an opportunity to make some cash from the situation. Citing some conditions, facts and assumptions, he believes the company's stock is about to rise tremendously- if the situation persists for a short while.
"Under these assumptions, the company’s share price five years from now would rise to NGN83.85 from its current level of NGN54.00. If we add five years of dividends to that price, investors would reap an annualized return of 11.4%."
"As for me, I’m staying on the sidelines for the time being, but if the stock’s price drops further on no substantive news, I may be enticed to pick up a few shares," he wrote.
click here to read his article
#RyanHoover #Nigeria #GSK